Emirate of Abu Dhabi
Publication of Offering Circular and
Pricing Supplements
The following offering circular (the
Offering Circular) and
pricing supplements (the Pricing
Supplements) are available for viewing:
1. Offering Circular dated 22
April 2024 in respect of the Emirate of Abu Dhabi (the Issuer)'s
Global Medium Term Note Programme (the Programme);
2. Pricing Supplement in
relation to the issue of U.S.$ 1,750,000,000 4.875 per cent. Notes
due 2029 by the Issuer under the Programme;
3. Pricing Supplement
in relation to the issue of U.S$1,500,000,000 5.000 per cent.
Notes due 2034 by the Issuer under the Programme;
4. Pricing Supplement
in relation to the issue of U.S.$1,750,000,000
5.500 per cent. Notes due 2054 by the Issuer under the
Programme.
Please read the disclaimer below
"Disclaimer - Intended Addressees" before attempting to access this
service, as your right to do so is conditional upon complying with
the requirements set out below.
To view the full document, please paste the
following URL into the address bar of your browser.
http://www.rns-pdf.londonstockexchange.com/rns/4805M_1-2024-4-29.pdf
http://www.rns-pdf.londonstockexchange.com/rns/4805M_2-2024-4-29.pdf
http://www.rns-pdf.londonstockexchange.com/rns/4805M_3-2024-4-29.pdf
http://www.rns-pdf.londonstockexchange.com/rns/4805M_4-2024-4-29.pdf
For further information, please
contact:
Department of Finance
P.O. Box 30, Abu Dhabi
United Arab Emirates
Telephone: +971 2
810 1713
Email:
dmo@addof.gov.ae
DISCLAIMER - INTENDED ADDRESSEES
The Pricing Supplements referred to
above must be read in conjunction with the Offering Circular in
respect of the Programme for the purposes of the Regulation (EU)
2017/1129.
Please note that the information
contained in the Pricing Supplements and the Offering Circular may
be addressed to and/or targeted at persons who are residents of
particular countries (specified in the Pricing Supplements and/or
the Offering Circular) only and is not intended for use and should
not be relied upon by any person outside these countries and/or to
whom the offer contained in the Pricing Supplements and/or the
Offering Circular is not addressed. Prior to relying on the
information contained in the Pricing Supplements and/or the
Offering Circular you must ascertain from the Pricing Supplements
and Offering Circular whether or not you are part of the intended
addressees of the information contained therein.
The securities referred to in the
Pricing Supplements have not been and will not be registered under
the United States Securities Act of 1933, as amended (the
Securities Act) or with any securities regulatory authority of any state or
other jurisdiction of the United States, and may not be offered or sold within the United States except
pursuant to an exemption from, or in a transaction not subject to,
the registration requirements of the Securities Act. Prospective
purchasers are hereby notified that sellers of the Notes may be
relying on the exemption from the provisions of Section 5 of the
Securities Act provided by Rule 144A.
The Pricing Supplements and the
Offering Circular have been made available to you in an electronic
form. You are reminded that documents transmitted via this medium
may be altered or changed during the process of electronic
transmission and consequently none of the Issuer, its advisers nor
any person who controls any of them nor any director, officer,
employee nor agent of it or affiliate of any such person accepts
any liability or responsibility whatsoever in respect of any
difference between the Pricing Supplements and the Offering
Circular made available to you in electronic format and the hard
copy version available to you on request from the
Issuer.
Your right to access this service is
conditional upon complying with the above requirement.